Company Overview and News

KL shares remains negative at mid-morning

2018-09-28 malaymail
KUALA LUMPUR, Sept 28 — Shares on Bursa Malaysia remained in negative territory at mid-morning bucking the regional trend, following overnight gains on Wall Street, dealers said.
PBLOF 5072 1295 BSMAF 1818

Axiata, FGV, KIP REIT, Daya Materials, Malaysia Smelting, Kim Loong, Crescendo, Hiap Teck, Harrisons, AWC, Perisai and Tropicana Corp

2018-09-27 theedgemarkets - 1
KUALA LUMPUR (Sept 27): Based on corporate announcements and news flow today, companies in focus on Friday (Sept 28) may include: Axiata Group Bhd, FGV Holdings Bhd, KIP Real Estate Investment Trust (REIT), Daya Materials Bhd, Malaysia Smelting Corp Bhd, Kim Loong Resources Bhd, Crescendo Corp Bhd, Hiap Teck Venture Bhd, Harrisons Holdings (Malaysia) Bhd, AWC Bhd, Perisai Petroleum Teknologi Bhd and Tropicana Corp Bhd.
5008 0047 5027 SGPRY 5072 6888 SGPRF 0091 S20 AXXTF

KLCI erases earlier loss, crosses 1,800-level

2018-09-27 theedgemarkets
KUALA LUMPUR (Sept 27): The FBM KLCI erased its earlier losses and rose at mid-morning to cross the 1,800-point level.
5072 8621 7158 BATS 4162 7215 2089 5199 5347 3301 7668 TNABY AXXTF HIPEF PNAGF UPBMF 1163 5202 8311 6033 2593 5139 PNADF 0900 6888 TNABF 3719

Hiap Teck Venture to boost financial performance

2018-08-14 theedgemarkets
IN the last three years, fortunes have been mixed for businessman Tan Sri David Law Tien Seng, or TS Law. His strategic investment in Tungsten Mining NL appears to be bearing fruit. The Australian-listed resources company has developed a substantial portfolio of advanced tungsten resource projects and it is now poised to take advantage of the improved outlook for the speciality metal. (See sidebar)
TGN 5072

Stocks of water pipe makers rise as Selangor govt offers for Splash

2018-08-03 theedgemarkets
KUALA LUMPUR (Aug 3): Shares of water pipe manufacturers rose today as the Selangor government announced it would offer RM2.25 billion to take over Syarikat Bekalan Air Selangor Sdn Bhd (Splash), in a move towards solving the impasse over the state's water assets.
5843 9318 5072 7014 5056

Hiap Teck gapped up, says AllianceDBS Research

2018-07-18 theedgemarkets
KUALA LUMPUR (July 19): AllianceDBS Research said Hiap Teck Venture Bhd (Hiaptek) had on July 18 gapped up to reach a high of 35 sen before closing at the day’s low of 33.5 sen (up 1 sen or 3.07%).

Challenging outlook seen for construction in 2H18

2018-07-18 theedgemarkets
Construction sector Maintain neutral: Post-14th general election, the new Pakatan Harapan government embarked on a review of all megaprojects, as promised in its election manifesto. The Kuala Lumpur-Singapore high-speed rail (RM60 billion to RM70 billion) and mass rapid transit Line 3 (MRT3) (RM40 billion) were shelved shortly thereafter. Although there were reports regarding the revival of these projects, we reckon that chances are slim in the near term.
9261 5843 3204 5797 5072 7014 9679 7078 5056

Hiap Teck’s Eastern Steel resumes operation

2018-07-18 theedgemarkets
KUALA LUMPUR: Hiap Teck Venture Bhd said yesterday its blast furnace at Eastern Steel Sdn Bhd has resumed production, after a halt of nearly three years.

Hiap Teck edges higher as Eastern Steel resumes operation

KUALA LUMPUR: Hiap Teck Venture Bhd rose on Wednesday as its blast furnace at Eastern Steel Sdn Bhd has resumed production.

Trading ideas: Advancecon, Hiap Teck, Velesto, KPS, MAHB

KUALA LUMPUR: Advancecon Holdings Bhd, Hiap Teck Venture Bhd , Velesto Energy Bhd , Kumpulan Perangsang Selangor Bhd (KPS) and Malaysia Airports Holdings Bhd are among the stocks to watch, according to JF Apex Research.
5843 5072 MYPRY 5014

KLCI to trend sideways, immediate hurdle at 1,748

2018-07-17 theedgemarkets
KUALA LUMPUR (July 18): The FBM KLCI is seen trending sideways today with immediate hurdle at 1,748.
5843 5754 6084 7251 5072 4723 9083 MYPRY 5014 7088

Advancecon, Hiap Teck, Poh Huat, Velesto, Barakah Offshore, JAKS, Star, Utusan, Kumpulan Perangsang Selangor, MyEG, MAHB and Kumpulan Jetson

2018-07-17 theedgemarkets
KUALA LUMPUR (July 17): Based on corporate announcements and news flow today, companies that may be in focus tomorrow (July 18) may include the following: Advancecon Holdings Bhd, Hiap Teck Venture Bhd, Poh Huat Resources Holdings Bhd, Velesto Energy Bhd, Barakah Offshore Petroleum Bhd, JAKS Resources Bhd, Star Media Group Bhd, Utusan Melayu (Malaysia) Bhd, Kumpulan Perangsang Selangor Bhd, My EG Services Bhd, Malaysia Airports Holdings Bhd and Kumpulan Jetson Bhd.
5843 5754 6084 7251 5072 4723 9083 MYPRY BSMAF 5014 7088 1818

Hiap Teck’s Eastern Steel resumes operation

2018-07-17 theedgemarkets
KUALA LUMPUR (July 17): The wait is over as Hiap Teck Venture Bhd announced today its blast furnace at Eastern Steel Sdn Bhd has resumed production finally, after a halt of nearly three years.

Hiap Teck shares take a tumble after profit fall

KUALA LUMPUR: Shares in Hiap Teck Venture Bhd were down 8% in early trade after the company reported a 95% slump in profits in the third quarter ended April 30.

Trading ideas: Kelington, Gabungan AQRS, NTPM, Serba Dinamik, Hiap Teck

KUALA LUMPUR: JF Apex Research expects Kelington Group Bhd , Gabungan AQRS Bhd , NTPM Holdings Bhd , Serba Dinamik Holdings Bhd and Hiap Teck Venture Bhd to be among the stocks to watch on Tuesday.
5226 5072 5066 0151

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...